key: cord-1014185-oevpc9mi
authors: Sujan, Md. Safaet Hossain; Tasnim, Rafia; Islam, Md. Saiful; Ferdous, Most. Zannatul; Apu, Md. Abdur Rahman; Musfique, Md. Miftah; Pardhan, Shahina
title: COVID-19-specific diabetes worries amongst diabetic patients: The role of social support and other co-variates
date: 2021-06-25
journal: Prim Care Diabetes
DOI: 10.1016/j.pcd.2021.06.009
sha: 4a50d56f7ed486561fdc634f7c95ba9cbaf0df3d
doc_id: 1014185
cord_uid: oevpc9mi

BACKGROUND: The COVID-19 pandemic has impacted every individual’s life. It has been shown that mortality in people with underlying diseases including diabetes has been high. The present study aimed to measure diabetes related worries (outcome) and their associations with social support and lifestyle (exposures) amongst people with diabetes during the COVID-19 pandemic. METHODS: An online cross-sectional survey was completed by 928 respondents (>18 years) between 15-11-2020 and 12-12-2020. The questionnaire comprised four sections: socio-demographic details, diabetic-related worries, social support, and behavioral changes due to COVID-19. Descriptive statistics, correlations and hierarchical regression analysis were performed in the study. RESULTS: Data from 928 respondents (51.61% male; mean age = 52.48 [SD = 11.76]; age range = 18-86 years) were analyzed. The mean score for COVID-19 specific diabetes worries was 3.13 out of 8. Hierarchical regression analysis showed that the mean COVID-19-specific diabetes worries score was significantly associated with lower age, cigarette smoking, perceived poor health status, presence of other diabetic complications. Lack of social support from family, friends, work colleagues and diabetes care team and also eating more than usual were also significantly associated with COVID-19 specific diabetes worry. CONCLUSIONS: Diabetes related worries were strongly associated with a lack of social support during the COVID-19 pandemic. The findings suggest the need of social support as well as improving knowledge and guidelines is important for people with diabetes during the COVID-19 pandemic.

The recent emergence of COVID-19 has had a greater impact on people with comorbid conditions such as diabetes, hypertension, coronary heart disease, obesity, cancer and HIV/AIDS. 1, 2 Diabetes has been the second most common comorbidity (9.7%) among COVID-19 patients after cardio-metabolic disorders (12.5%). 1, 3 In 2019, the International Diabetes Federation (IDF) reported that 465 million (9.3%) people in the world were diagnosed with diabetes, and by 2045 the figure is predicted to grow to 700 million. 4 About 79% of people with diabetes live in low-income or middle-income countries, with more than 60% living in Asian countries. 5 In Bangladesh, there were 7.1 million people suffering with diabetes in 2015, with 3.7 million undiagnosed cases and nearly 129,000 deaths. 4, 6 Other reports suggest that there are almost 10 million diabetic patients in Bangladesh 7 with almost one in ten adults living with diabetes. 8 Nevertheless, to date, there are no data of how many people with diabetes patients have been infected with COVID-19 and what the mortality rate is in Bangladesh.

It is known that people who are living with chronic diseases such as diabetes are at increased risk of morbidity and mortality if they are infected with COVID-19. [9] [10] [11] [12] Maintaining good glycemic regulation is therefore important method in order to avoid complications arising from COVID-19. 13, 14 It is also known that diabetes management may be difficult as a result of government policies to regulate transmission such as social distancing and lockdowns. It is likely that diabetic individuals will face barriers in controlling their glycemic levels. These can include restricted access to healthcare, limited availability of fresh food, and reduced physical activity due to confinement. 13 Like many countries, in order to reduce the spread of the virus, J o u r n a l P r e -p r o o f the government in Bangladesh imposed strict social isolation and home quarantine measures [15] [16] [17] that would invariably affect regular physical movement and healthcare access.

The COVID-19 has an immense negative impact on diabetic patients. A previous study reported that individuals admitted to intensive care units (ICU) were more likely to have preexisting diabetes compared to patients with the COVID-19 who did not receive intensive care. 18 As diabetes mellitus and cardiovascular conditions are contributing factors for worsening COVID-19 severity and consequences, including higher infection and death rates. 19 Individuals with such medical conditions are more likely to suffer from mental health problems such as depression panic attacks and anxiety. 20 A recent study conducted in Brazil reported emotional distress (29.2%), eating disorders (75.8%), and moderate/severe sleeping disorders (77.5%) among diabetes patients during the COVID- 19. 21 It is to be expected that the COVID-19 epidemic, mass media coverage of the trajectory of the pandemic worldwide, and the terrifying death rates would lead to a decrease in mental wellbeing and increase in psychological disorders, including anxiety, depression and stress. [22] [23] [24] We hypothesized that these mental health parameters like worry would be higher in people with diabetes due to the higher risk of mortality and morbidity in this group, 25 making them even more vulnerable to worries. This in turn would affect their glycemic control. It is also likely that the management routine of people with diabetes has been disrupted, increasing worries amongst patients and leading to changes in their behavior. However, during this crucial time, people with diabetes p may also experience reduced social support due to various government restrictions. In addition to uncontrolled diabetes can increase the risk of diabetic complications such as retinopathy, neuropathy, diabetic foot and nephropathy. 26, 27 Several studies conducted with different cohorts have included general population, university students, medical students, slum-dwellers, health workers, and COVID-19 survivors have highlighted various mental health problems (e.g., anxiety, depression, panic, stress, posttraumatic stress disorder, suicidal ideation and addictive behaviors such as problematic use of smartphone, internet, social media) in Bangladesh during the pandemic. [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] To date, there is no prior study examining COVID-19-specific worries and diabetes related social-support among diabetic patients in Bangladesh. We developed a questionnaire based on published literature to assess worries, 25 social-support and behavioral changes among people with diabetes during the COVID-19 pandemic. Consequently, the present study aimed to assess the diabetes related worries, and to determine their factors associated with social support and lifestyle among the diabetic patients due to the COVID-19 outbreak in Bangladesh.

A cross-sectional study design was utilized for conducting the present study. Convenient sampling technique also utilized in the study. Data were collected between 15 November and 12 December 2020, during the second wave of the COVID-19 pandemic in Bangladesh. The target population were Bangladeshi citizens who could speak and understand the common language Bangla. Participants had to have been diagnosed with diabetes for at least six months prior to the study. A self-reported and semi-structured e-questionnaire was developed from previous literature. 25 This was disseminated via social platforms (such as Facebook, WhatsApp, online blogs, etc.). Before data collection, a pilot test comprising 50 samples was carried out to ensure the validity and reliability of the questionnaire. These data were not included in the final sample. Where needed, data were collected with the help of Research Assistants (RA) who had access to diabetic patients. For participants above the age of 70 years, those who did not have any smartphones or were digitally illiterate, responses were collected by family members who completed the online questionnaire. The inclusion criteria for the participants included being (i) above 18 years old, (ii) diagnosed as diabetese patient at least more than 6 months ago, and (iii) Bangladeshi citizen. The exclusion criteria were being (i) individual with no diabetes, and (ii) incomplete survey.

The sample size was calculated using the following equation: Here, n = number of samples z = 1.96 (95% confidence level) p = prevalence estimate (50% or .5) (as no study found) q = (1-p) d = Precision of the prevalence estimate

The calculated sampling size was 384. There are limited studies to base this on however p = .5 was initially selected. Our sample size exceeds this by a substantial proportion. Out of 1052 received responses, 928 responses were analyzed after removing incomplete or ineligible data.

The survey was designed in such a way that individuals first gave informed consent by accepting the fact that they were willingly and voluntarily participating in this study. There was no compensation for completing the questionnaire. Following that, a confirmation of their J o u r n a l P r e -p r o o f diabetes status was obtained by 'Have you been diagnosed as having diabetes?' if the answer of the person was "no", then a blank response was submitted. If the individual responded "yes", the full survey form became accessible.

The e-questionnaire consisted of four sections: socio-demographic, COVID-19-specific diabetes worries, social support, and behavioral changes due to the COVID-19.

Socio-demographic data included questions on age, sex, occupation, marital status (single/married/divorced or widow or widower), and residence (urban/rural). In addition, data on smoking habits (yes/no), physical exercise (yes/no), and average number of sleep hours were acquired. Average sleeping hours were classified into three categories according to previous literature: normal (7-9 h) , less than average (< 7h), or more than average (> 9h). 33, 36 Less than average (< 7h) and more than average (> 9h) of sleep were classed as sleep disturbance. Self-rated health status was obtained from three possible responses: good, moderate or poor (Table 1) .

With regards to assessing COVID-19-specific diabetes worries, a total of eight questions with dichotomous responses (yes/no) were asked during the survey, adopted from previous published literature 25 (Table 2 ). Respondents were also asked additional questions regarding diabetes, including type of diabetes (type 1/type 2/LADA/gestational), and the presence of diabetic complications (e.g., retinopathy, nephropathy, neuropathy, and foot ulcer).

Social support related data were collected by asking five questions ( 

Behavioral changes due to the COVID-19 pandemic were ascertained using 'yes/no' questions (Table 3 : items 6-11). These included questions such as are you measuring your blood glucose level more than usual due to fear of COVID-19? are you taking medicine more regularly and carefully than before? are you doing less physical exercise than before? are you doing more physical exercise than before? are you eating less than before? and are you taking more food than before?

Descriptive statistics (i.e., frequencies, percentages, means, standard deviations) were calculated. Inferential statistics included conducting t-tests or one-way Analysis of Variance (ANOVA) to determine the mean differences in the score of COVID-19-specific diabetes worries in relation to background variables, social support, and behavioral changes due to COVID-19. Additionally, Skewness, Kurtosis, and Pearson correlation between all items regarding social support and behavioral changes in relation to the COVID-19-specific diabetes worries were calculated. Parameters that were statistically significant in the group difference analyses (t-tests/ANOVA) and Person correlations analyses, were included in a hierarchical regression analysis. These were categorized into different blocks: 

The mean score of COVID-19-specific diabetes worries was 3.13 (SD = 1.90) out of a total score of 8, with a higher score indicating the higher level of COVID-19-specific diabetes worries. 

The mean score of COVID-19-specific diabetes worries was significantly higher (p < .05) among participants who were of lower age, lived in rural areas, had sleep disturbance, smokers, not physically active, self-reporting poor health status and with multiple complications due to diabetes (Table 1) . Table 3 shows reliability indices, the mean score, and Pearson correlations between all items regarding social support (items 1-5), behavioral changes (items 6-11) computed for COVID-19 diabetic-specific worries (item 12). COVID-19-specific diabetes worries were negatively correlated with social support (i.e., from family/friends/relatives, colleagues, diabetes care teams, other people in the community [neighbors] , and other people with diabetes); conversely, behavioral changes due to COVID-19 (i.e., checking blood glucose more often than usual, less exercise than usual, eating less than usual, and eating more than usual) were positively related with COVID-19-specific diabetes worries.

The findings of the hierarchical regression analysis predicting COVID-19-specific diabetes worries are presented in Table 4 The COVID-19-specific diabetes worries were significantly associated with lower age, smokers, poor self-reported health status, presence of multiple diabetes complications, lack of social support (i.e., from family/friends/relatives, colleagues, and diabetes care teams), and eating more compared to pre-COVID period (Table 4) .

Other variables (i.e., residence, sleep disturbance, physical exercise, and other people in your community [neighbors], other people with diabetes, checking blood glucose more often than usual, less exercise than usual, and eating less than usual) were not shown to be significant.

The COVID-19 pandemic has taken a heavy toll on lives all over the world and influenced the wellbeing of people. Individuals with comorbidities such as diabetes may have specific worries about COVID-19, as these individuals are at an elevated risk for severe infection and mortality. 41 Our data also revealed that people who perceived their own health as poor were more worried.

It is likely that during this pandemic, regular medical checkups may have been delayed or canceled as hospitals concentrate on COVID-19 patients. It is also likely that patients are less eager to visit their doctor during the pandemic. As diabetes is a chronic condition, regular consultations are important. 42 Furthermore, the unpredictability of the disease and social immobility may lead to mental health problems.

The current pandemic would be particularly challenging for diabetic patients, especially for those who develop complications related to diabetes. In this study, we found that COVID-19 J o u r n a l P r e -p r o o f related worries were greater among diabetes patients suffering from diabetic complications.

The risk of diabetes related complications (such as cardiovascular and renal complications, neuropathy, blindness, etc.) 50 may increase during the pandemic as a result of uncontrolled diabetes, requiring further care for individuals. Major changes have already been observed in the healthcare systems which interrupt existing best practices that have been set up to reduce the risk of diabetic related complications. 45 The risk of complications may increase due to reduced access to medication, diabetic-related supplies (syringes, glucose strips) medical consultations, and timely laboratory results during the pandemic. 41 Moreover, it has been shown that a higher incidence of cardiac and pulmonary problems during COVID-19 result in adverse outcomes for diabetic patients. 45 Our study suggests that diabetes patients without social support (i.e., from family/friends/relatives, colleagues, and diabetes care teams) are more worried about being affected by COVID-19 than patients who have social support, agreeing with a previous study that reported that feeling isolated would lead to increased worry about COVID-19 among diabetes patients. 25 The management of diabetes can be very complicated and requires lifelong involvement and significant lifestyle changes. 51 Family and social support provide practical assistance to patients, and can help alleviate the burden of living with the disease. 51 Since diabetes is a chronic condition that demands substantial change in behavior and adherence to a diet, social support is seen as one of the main factors for patients to acquire self-confidence in being able to self-care. 52 Diabetes is sometimes called the "family disease" 52 as it influences all family members. Patients therefore need continued support to preserve their physical and mental health, especially in critical situations such as COVID-19 pandemic. In addition, as mobility is limited in many parts of the world in order to control the pandemic, 2 it has become a cause of suffering, particularly for those who need social support. This is amplified in those who are elderly and live alone.

Our data also suggest that patients with diabetes were eating more compared to normal, and this was significantly associated with COVID-19 related worries in this group. As people with poor immune systems are more susceptible to COVID-19, 53 individuals with diabetes may try to seek to enhance their immune system by eating more than before. Normal dietary schedule is then disrupted resulting in change in food intake and leading to uncontrolled blood glucose levels. 2

Limitations This study has a number of limitations. Firstly, the study was cross-sectional in nature, so it does not establish the causality of any of the variables. In this respect, a longitudinal study is required for the better understanding of diabetic patients' behavior and their COVID-19 related specific worries. Secondly, the study used an online-based self-reporting method that may be vulnerable to social desirability and memory recall bias. Moreover, since the study was conducted via online methods and used the self-reported status for diagnosis of diabetes mellitus, it may be possible that people with no diabetes could have completed the survey.

However, this was mitigated by the fact that if they responded 'no' to a question that asked if they had diabetes then the online survey was closed before they could respond to any further questions.

This study represents the high prevalence of worries and significant change in behavior among people with diabetes during the COVID-19 pandemic. These findings suggest the need for improved support for people with diabetes to manage their worries and behavior, especially those patients with other diabetic complications. Providing community support and helplines would help mediate the worries and isolation in people with diabetes. It is also important healthcare providers deliver appropriate advice and care to diabetic patients both during and beyond the current COVID-19 pandemic. The findings suggest a need for a prospective study among patients with diabetes in Bangladesh to investigate diabetes related worries in relation to changed social support and lifestyles as a result of COVID-19 pandemic.

All of the authors declare no known conflict of interest. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f Social support : Items number (1-5) were scored 1-3 (i.e., 1 = Not supportive, 2 = Somewhat supportive, and 3 = Very supportive);

Behavioral changes: Items number (6-11) were scored 0-1 were scored as yes/no (i.e., 0 = No, and 1 = Yes); and COVID-19-specific diabetes worries: The higher score indicates the greater level of COVID-19-specific diabetes worries.

* p < .05, ** p < .01.

J o u r n a l P r e -p r o o f 

COVID-19 and diabetes: Knowledge in progress

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

Commentary: COVID-19 in patients with diabetes

Prevalence of diabetes and pre-diabetes in Bangladesh: a systematic review and meta-analysis

Global estimates of diabetes prevalence for 2013 and projections for 2035

Obesity blamed for alarming rise in childhood diabetes

Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey

COVID-19 and endocrine diseases. A statement from the

Diabetes, infection risk and COVID-19

Diabetes self-management amid COVID-19 pandemic

Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature

Physical inactivity and sedentary behaviors in the Bangladeshi population during the COVID-19 pandemic: An online cross-sectional survey

Knowledge, attitudes and practices associated with the COVID-19 among slum dwellers resided in Dhaka City: a Bangladeshi interview-based survey

Knowledge, attitude, and practice regarding COVID-19 outbreak in Bangladesh: an online-based cross-sectional study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Anxiety symptoms and the risk of diabetes mellitus in Australian women: evidence from 21-year follow-up. Public J o u r n a l P r e -p r o o f Health

Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing

2019-nCoV epidemic: Address mental health care to empower society

The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease)

Posttraumatic stress disorder during the COVID-19 pandemic: upcoming challenges in Bangladesh and preventive strategies

Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries

Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh

Chronic kidney disease hotspots in developing countries in South Asia

Problematic smartphone and social media use among Bangladeshi college and university students amid COVID-19: The role of psychological wellbeing and pandemic related factors. Front psychiatry

Prevalence and correlates of anxiety and depression in frontline healthcare workers treating people with COVID-19 in Bangladesh

The impact of the COVID-19 pandemic on the mental health of the adult population in Bangladesh: a nationwide cross-sectional study

The Psychometric Properties of the Bangla Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): A Large-scale Validation Study. Res Sq

Depressive symptoms associated with COVID-19 preventive practice measures, daily activities in home quarantine and suicidal behaviors: Findings from a large-scale online survey in Bangladesh. Under Rev

Suicidal ideation among Bangladeshi university students early during the COVID-19 pandemic: Prevalence estimates and correlates

Panic and generalized anxiety during the COVID-19 pandemic among Bangladeshi people: an online pilot survey early in the outbreak

Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh

Problematic internet use among young and adult population in Bangladesh: Correlates with lifestyle and online activities during the COVID-19 pandemic

Psychological responses during the COVID-19 outbreak among university students in Bangladesh

Correlates of financial concerns, depression , and posttraumatic stress disorder symptoms among impoverished urban dwelling individuals in Bangladesh during the COVID-19 pandemic: A face-to-face interview approach

Prevalence and factors associated with depression and anxiety among first-year university students in Bangladesh: a crosssectional study

Immediate psychological responses during the initial period of the COVID-19 pandemic among Bangladeshi medical students

COVID-19 impact on people with diabetes in South and Central America (SACA region)

Diabetes care during COVID-19 lockdown at a tertiary care centre in India

Characteristics, management and outcomes of critically ill COViD-19 patients admitted to ICU in hospitals in Bangladesh: A retrospective study. medRxiv

Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19

Diabetes and COVID-19

Diabetes is a risk factor for the progression and prognosis of COVID-19

The effect of smoking on COVID-19 severity: A systematic review and meta-analysis

Smoking is associated with COVID-19 progression: a meta